One of the first public exchange-traded funds (ETF) for the cannabis industry has now added 10 more listings for investors to rely on.

On Monday (March 19) Horizons ETFs Management announced a quarterly rebalance for the Horizons Marijuana Life Sciences Index ETF (TSX:HMMJ). Thanks to this update, an additional 10 more cannabis stocks, increase the ETFs holdings to 37 as of Tuesday.


“It’s exciting to see an increase in the number of investable companies that qualify to be included in HMMJ’s portfolio,” Steve Hawkins, president and Co-CEO of Horizons ETFs said in a statement.

Hawkins added as the industry moves closer to legalization for adult-use of cannabis in Canada, he has seen the entire sector “rapidly grow in size and breadth.”

This growth was made even more evident for the Horizons ETFs Management as it launched an additional marijuana ETF this year. The Horizons Emerging Marijuana Growers Index ETF (AQN:HMJR) launched on the Aequitas NEO Exchange on February 14.

The most recent ETF offers investors exposure to marijuana producers that are smaller in market capitalization.

The brand new holdings available on the Horizons Marijuana Life Sciences Index ETF are:

“Our clinical approach and pipeline of products are unique and being added to this index reinforces the credibility of our approach to the financial community,” Bernard Fortier, CEO of Tetra Bio-Pharma said in a statement.

So far in 2018, the Horizons Marijuana Life Sciences Index ETF has decreased in value 8.30 percent, up until market closure on Monday, representing a loss of $1.76 per share. At market closure on Tuesday (March 20), the ETF finished the day at $19.04.

Are investors getting the proper value from investing in ETFs?

Providing commentary for the industry, Alan Brochstein, cannabis analyst with 420 Investor wrote a column in Forbes detailing why, in his opinion, investors may want to hold on cannabis-focused ETFs despite their appeal.

“While I like the concept of an investment fund targeting cannabis stocks, the ones that have been created thus far are not well constructed for the most part,” Brochstein wrote.

Brochstein said his initial reservations with Horizons Marijuana Life Sciences Index ETF related to the inclusion of some biotech stocks, which he opined have had a negative impact on the performance of the index.

He added this ETF is a bet on Canadian licensed producers (LPs), which represent 74 percent of the fund. Brochstein conceded why investors see interest in this particular ETF:

While I continue to believe that most investors can likely do better than HMMJ by picking a few large Canadian LPs, thus avoiding the 0.75 [percent] management fee as well as exposure to a few names that don’t really make sense, I can see the appeal to those investing smaller amounts of money but who want diversification.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Editor’s Note: This story was updated to reflect the market closure data for the Horizons Marijuana Life Sciences Index ETF.

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: Beleave, HIKU Brands, and Isodiol International are clients of the Investing News Network. This article is not paid-for content.

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today its participation in the following investor conferences:

  • Needham 2nd Annual Virtual Cannabis Conference – March 3 rd , 2021 – Management will participate in virtual one-on-one meetings.
  • 33rd Annual Roth Conference – March 15 th -17 th , 2021 – Charlie Bachtell, CEO and Co-Founder, will participate in a Fireside Chat and management will later participate in virtual one-on-one meetings on April 7 th .
  • Stifel Multi-Sector Conference – April 21 st , 2021 – Management will participate in virtual one-on-one meetings.

About Cresco Labs

Keep reading... Show less

Green Thumb Industries, a leading cannabis consumer packaged goods company and owner of Rise™ Dispensaries, is expanding key partnerships and creating scholarships earmarked for those from communities most impacted by the war on drugs as part of its corporate social responsibility program. The scholarships will be granted to a total of four students for programs at the Cleveland School of Cannabis in Ohio and Olive-Harvey College in Illinois. Additionally, Green Thumb will continue its support of Cabrini Green Legal Aid and partner with the North Lawndale Employment Network in Chicago as part of ongoing collaborations that include financial support, volunteerism and awareness initiatives.

Building on the foundation of Green Thumb’s LEAP initiative, which provided pro-bono support for social equity license applicants in Illinois and which will soon offer business incubator resources to newly awarded social equity entrepreneurs, these impactful partnerships mark a critical next step in prioritizing diversity, equity, and inclusion in the cannabis industry.

Keep reading... Show less

All five flavours of the Company’s KOIOS™ nootropic beverage product are now being carried by Jensen’s, a regional supermarket chain operating in the San Diego, Los Angeles, and Palm Springs areas of Southern California. This placement of KOIOS™ follows several other recent placements of the Company’s beverage products in regional supermarket chains across the United States as part of a strategy to passively build market share in specific geographical areas.

Koios Beverage Corp. (CSE: KBEV; OTC: KBEVF) (the “Company” or “Koios”) is pleased to announce that the full range of five flavours of its KOIOS ™ nootropic beverages can now be purchased at all grocery stores operated by Jensen’s Foods (“Jensen’s”), a long-established family-owned grocery chain operating in the San Diego, Los Angeles, and Palm Springs areas of Southern California. In a press release dated February 19, 2021 the Company announced another chain-wide placement of KOIOS ™ nootropic beverages on the west coast of the United States with Market of Choice in Oregon. With this placement of KOIOS ™ in Jensen’s supermarkets, the Company’s beverage products are now carried in approximately 180 retail stores on the west coast, out of a total of more than 4,000 retail stores nationwide.

Keep reading... Show less

 Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) announces that Philip Young, CEO and Director, and Maghsoud Dariani, Chief Science Officer will be presenting on Thursday, February 25th, 2021 at 5:45 pm EST at “The Gold Standard in Psychedelic Investment, Psychedelic Capital Virtual Investment Conference”, a platform showcasing the top companies, latest IPOs, newest opportunities, and deepest industry insights.

As a presenting sponsor, the Company will connect directly with some of the earliest moving investors in the psychedelic industry and reach an audience of 2,000+ investors. Presentations are 30 minutes in length, with 10 minutes allocated to a one-on-one Q&A session with the audience.

Keep reading... Show less

As Canadian operators race to strengthen their positions in the cannabis landscape, are international pursuits outside North America still top of mind?

The role that mergers and acquisitions (M&A) have played in the expansion of Canadian companies across the globe has been monumental for the growth of the cannabis industry. Now the space has reached a critical point as the demands of the US market increase.

Keep reading... Show less